Journal of Ocular Pharmacology and Therapeutics

Papers
(The H4-Index of Journal of Ocular Pharmacology and Therapeutics is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Eyes on New Product Development67
Eyes on New Product Development33
Ocular Safety and Toxicokinetics of Bevacizumab-bvzr (Zirabev), a Bevacizumab Biosimilar, Administered to Cynomolgus Monkeys by Intravitreal Injection32
Eyes on New Product Development23
Preformulation-Assisted Design of Ketorolac Tromethamine for Effective Ophthalmic Delivery20
Novel Combined Lidocaine/Povidone Iodine Delivery System for Preintravitreal Injection20
Clinical Pharmacokinetics of Atropine Administered Ocularly Using an Ultrasensitive Bioanalytical Assay18
Antibiotic Prescribing Patterns Among U.S. Ophthalmologists and Optometrists from 2018 to 2021 in the Medicare Part D Database17
Age-Related Macular Degeneration Pathophysiology and Therapeutic Potential of Tocotrienols: An Update17
Topical Administration of Bevacizumab to Facilitate the Functional Filtering Bleb After Trabeculectomy in the Rabbit17
Efficacy of Intravitreal Dexamethasone After Combined Phacoemulsification and Pars Plana Vitrectomy for Diabetic Tractional Retinal Detachments16
Call for Special Issue Papers: Ocular Drug Delivery Technology Special Issue15
Discovery and Development of the Quininib Series of Ocular Drugs15
Effects of Topical Antiglaucomatous Medications on Conjunctival Thickness: A Prospective Anterior Segment Optical Coherence Tomography Study14
0.07282280921936